{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T17:12:27Z","timestamp":1781716347206,"version":"3.54.5"},"reference-count":65,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T00:00:00Z","timestamp":1740096000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Medical Faculty University of Belgrade","award":["451-03-66\/2024-03\/200110"],"award-info":[{"award-number":["451-03-66\/2024-03\/200110"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>Background: Spinal muscular atrophy (SMA) is a severe neuromuscular disorder characterized by the degeneration of alpha motor neurons in the spinal cord, leading to progressive proximal muscle weakness and paralysis. SMA is clinically categorized into four phenotypes based on age of onset and motor function achieved. Patients with SMA type 3 (juvenile, Kugelberg-Welander disease) initially have the ability to walk unaided, but experience a gradual decline in motor abilities over time. However, their lifespan is not affected by the presence of the disease. Leptin, a cytokine-like hormone secreted by adipocytes, has receptors widely distributed in musculoskeletal tissues. Several studies suggest that adiponectin deficiency contributes to the development of insulin resistance, with lower adiponectin levels closely associated with greater insulin resistance and hyperinsulinemia. However, the role of adiponectin in different types of sarcopenia and its connection to insulin sensitivity remains controversial. The purpose of this study was to measure leptin and adiponectin levels in patients with SMA type 3 and explore their association with markers of insulin sensitivity. Methods: This cross-sectional study included 23 adult patients with SMA type 3 (SMA group) and 18 community-based healthy volunteers (control group), conducted from July 2020 to September 2024. Anthropometric parameters, body composition, body fat percentage, surrogate markers of insulin sensitivity (Homeostasis model assessment of insulin resistance index\u2014HOMA-IR and ISI Matsuda), and circulating levels of leptin and adiponectin were measured in all participants. Results: Insulin resistance was present in 91.3% of patients with SMA type 3, as determined by HOMA-IR and ISI Matsuda insulin sensitivity markers. In the control group, 64.7% had insulin resistance (IR) according to HOMA-IR, while 44.4% met the ISI Matsuda criterion for IR, showing a significant difference in peripheral insulin sensitivity between groups. A significant difference in serum adiponectin levels was observed between patients with SMA type 3 and the control group, whereas there was no significant difference in serum leptin concentrations. High adiponectin levels were observed in 50% of patients with SMA type 3. In the healthy control group, adiponectin levels positively correlated with ISI Matsuda and negatively correlated with HOMA-IR, confirming the insulin-sensitizing role of adiponectin. However, this correlation was not observed in patients with SMA type 3. Conclusions: Our results suggest that in this specific type of hereditary neuromuscular disease, the interplay between sarcopenia and insulin leads to adiponectin resistance, challenging the canonical narrative between insulin sensitivity and adiponectin, and indicating a need for further research.<\/jats:p>","DOI":"10.3390\/diagnostics15050529","type":"journal-article","created":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T09:26:32Z","timestamp":1740129992000},"page":"529","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Adiponectin and Leptin\u2014Considerations in Adult Patients with Spinal Muscular Atrophy Type 3"],"prefix":"10.3390","volume":"15","author":[{"given":"Marija","family":"Mileti\u0107","sequence":"first","affiliation":[{"name":"Clinic for Endocrinology, Diabetes and Metabolic Diseases, University Clinical Center of Serbia, 11000 Belgrade, Serbia"},{"name":"Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zorica","family":"Stevi\u0107","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia"},{"name":"Clinic of Neurology, University Clinical Center of Serbia, 11000 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2979-556X","authenticated-orcid":false,"given":"Stojan","family":"Peri\u0107","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia"},{"name":"Clinic of Neurology, University Clinical Center of Serbia, 11000 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7290-5181","authenticated-orcid":false,"given":"Milina","family":"Tan\u010di\u0107 Gaji\u0107","sequence":"additional","affiliation":[{"name":"Clinic for Endocrinology, Diabetes and Metabolic Diseases, University Clinical Center of Serbia, 11000 Belgrade, Serbia"},{"name":"Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8365-4840","authenticated-orcid":false,"given":"Jelena","family":"Rako\u010devi\u0107","sequence":"additional","affiliation":[{"name":"Institute of Histology and Embryology \u201cAleksandar \u00d0. Kosti\u0107\u201d, Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1935-9094","authenticated-orcid":false,"given":"Milo\u0161","family":"Stojanovi\u0107","sequence":"additional","affiliation":[{"name":"Clinic for Endocrinology, Diabetes and Metabolic Diseases, University Clinical Center of Serbia, 11000 Belgrade, Serbia"},{"name":"Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-8494-0320","authenticated-orcid":false,"given":"Bojan","family":"Markovi\u0107","sequence":"additional","affiliation":[{"name":"Clinic for Endocrinology, Diabetes and Metabolic Diseases, University Clinical Center of Serbia, 11000 Belgrade, Serbia"},{"name":"Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9977-5970","authenticated-orcid":false,"given":"Milo\u0161","family":"\u017darkovi\u0107","sequence":"additional","affiliation":[{"name":"Clinic for Endocrinology, Diabetes and Metabolic Diseases, University Clinical Center of Serbia, 11000 Belgrade, Serbia"},{"name":"Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,2,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1001\/archneur.1971.00490030102014","article-title":"Two early infantile hereditary cases of progressive muscular atrophy simulating dystrophy, but on a neural basis. 1891","volume":"25","author":"Werdnig","year":"1971","journal-title":"Arch Neurol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/BF01668496","article-title":"\u00dcber chronische spinale Muskelatrophie im Kindesalter, auf famili\u00e4rer Basis","volume":"3","author":"Hoffmann","year":"1893","journal-title":"Dtsch. Z. Nervenheilkd."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0960-8966(06)80015-5","article-title":"International SMA consortium meeting. (26\u201328 June 1992, Bonn, Germany)","volume":"2","author":"Munsat","year":"1992","journal-title":"Neuromuscul. Disord."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0022-510X(96)00284-5","article-title":"A collaborative study on the natural history of childhood and juvenile onset proximal spinal muscular atrophy (type II and III SMA): 569 patients","volume":"146","author":"Zerres","year":"1997","journal-title":"J. Neurol. Sci."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.nmd.2017.11.005","article-title":"Diagnosis and management of spinal muscular atrophy: Part 1: Recommendations for diagnosis, rehabilitation, orthopedic and nutritional care","volume":"28","author":"Mercuri","year":"2018","journal-title":"Neuromuscul. Disord."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/ana.23582","article-title":"Glucose metabolism and pancreatic defects in spinal muscular atrophy","volume":"72","author":"Bowerman","year":"2012","journal-title":"Ann. Neurol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.jpeds.2015.09.023","article-title":"Responses to fasting and glucose loading in a cohort of well children with spinal muscular atrophy type II","volume":"167","author":"Davis","year":"2015","journal-title":"J. Pediatr."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.pediatrneurol.2015.12.015","article-title":"Nutritional status and nutrient intake challenges in children with spinal muscular atrophy","volume":"57","author":"Mehta","year":"2016","journal-title":"Pediatr. Neurol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"101158","DOI":"10.1016\/j.molmet.2020.101158","article-title":"Type 2 diabetes subgroups and potential medication strategies in relation to effects on insulin resistance and beta-cell function: A step toward personalised diabetes treatment?","volume":"46","author":"Veelen","year":"2021","journal-title":"Mol. Metab."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1210\/jc.2014-2299","article-title":"Fasting and OGTT-derived measures of insulin resistance as compared with the euglycemic-hyperinsulinemic clamp in nondiabetic Finnish offspring of type 2 diabetic individuals","volume":"100","author":"Lorenzo","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/s00125-013-3121-8","article-title":"HOMA and Matsuda indices of insulin sensitivity: Poor correlation with minimal model-based estimates of insulin sensitivity in longitudinal settings","volume":"57","author":"Xiang","year":"2014","journal-title":"Diabetologia"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Mileti\u0107, M., Stevi\u0107, Z., Vujovi\u0107, S., Rako\u010devi\u0107, J., Tomi\u0107, A., Tan\u010di\u0107 Gaji\u0107, M., Stojanovi\u0107, M., Palibrk, A., and \u017darkovi\u0107, M. (2024). Glucose and lipid metabolism disorders in adults with spinal muscular atrophy type 3. Diagnostics, 14.","DOI":"10.3390\/diagnostics14182078"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.tem.2006.10.010","article-title":"The adipocyte-myocyte axis in insulin resistance","volume":"17","author":"Sell","year":"2006","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.cytogfr.2016.10.003","article-title":"Myokines and adipokines: Involvement in the crosstalk between skeletal muscle and adipose tissue","volume":"33","author":"Li","year":"2017","journal-title":"Cytokine Growth Factor Rev."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12950-018-0185-8","article-title":"The role of adipokines in skeletal muscle inflammation and insulin sensitivity","volume":"15","author":"Nicholson","year":"2018","journal-title":"J. Inflamm."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"3795","DOI":"10.1113\/JP283034","article-title":"Leptin mediates the regulation of muscle mass and strength by adipose tissue","volume":"600","author":"Collins","year":"2022","journal-title":"J. Physiol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0092-8674(01)00240-9","article-title":"Obesity and the regulation of energy balance","volume":"104","author":"Spiegelman","year":"2001","journal-title":"Cell"},{"key":"ref_18","first-page":"25","article-title":"The fat-free mass compartment influences serum leptin in men","volume":"142","author":"Vayreda","year":"2000","journal-title":"Eur. J. Endocrinol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/jcb.20521","article-title":"Leptin expression in human primary skeletal muscle cells is reduced during differentiation","volume":"96","author":"Solberg","year":"2005","journal-title":"J. Cell Biochem."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/31474","article-title":"A nutrient-sensing pathway regulates leptin gene expression in muscle and fat","volume":"393","author":"Wang","year":"1998","journal-title":"Nature"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.cyto.2012.08.021","article-title":"Human skeletal muscle releases leptin in vivo","volume":"60","author":"Mygind","year":"2012","journal-title":"Cytokine"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.coph.2004.01.009","article-title":"The complex effects of leptin on bone metabolism through multiple pathways","volume":"4","author":"Thomas","year":"2004","journal-title":"Curr. Opin. Pharmacol."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Arounleut, P., Bowser, M., Upadhyay, S., Shi, X.M., Fulzele, S., Johnson, M.H., Stranahan, A.M., Hill, W.D., and Hamrick, M.W. (2013). Absence of functional leptin receptor isoforms in the POUND (Lepr(db\/lb)) mouse is associated with muscle atrophy and altered myoblast proliferation and differentiation. PLoS ONE, 8.","DOI":"10.1371\/annotation\/3a7d6e24-137c-4603-93ca-879bec7fab80"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1152\/japplphysiol.01313.2006","article-title":"Leptin receptors in human skeletal muscle","volume":"102","author":"Guerra","year":"2007","journal-title":"J. Appl. Physiol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"10092","DOI":"10.1073\/pnas.0507519103","article-title":"Leptin (ob gene) of the South African clawed frog Xenopus laevis","volume":"103","author":"Crespi","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.cca.2012.12.007","article-title":"Role of leptin and adiponectin in insulin resistance","volume":"417","author":"Yadav","year":"2013","journal-title":"Clin. Chim. Acta"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.trsl.2014.04.008","article-title":"Adiposity distribution influences circulating adiponectin levels","volume":"164","author":"Guenther","year":"2014","journal-title":"Transl. Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1152\/ajpcell.00030.2008","article-title":"Adiponectin is expressed by skeletal muscle fibers and influences muscle phenotype and function","volume":"295","author":"Krause","year":"2008","journal-title":"Am. J. Physiol.-Cell Physiol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1093\/eurheartj\/ehn136","article-title":"Description of a local cardiac adiponectin system and its deregulation in dilated cardiomyopathy","volume":"29","author":"Skurk","year":"2008","journal-title":"Eur. Heart J."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1006\/bbrc.2001.5134","article-title":"Change in expression of GBP28\/adiponectin in carbon tetrachloride-administrated mouse liver","volume":"285","author":"Taniguchi","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.bone.2004.06.008","article-title":"Adiponectin and its receptors are expressed in bone-forming cells","volume":"35","author":"Berner","year":"2004","journal-title":"Bone"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.febslet.2007.11.070","article-title":"The physiological and pathophysiological role of adiponectin and adiponectin receptors in the peripheral tissues and CNS","volume":"582","author":"Kadowaki","year":"2008","journal-title":"FEBS Lett."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"7991","DOI":"10.1074\/jbc.M700098200","article-title":"Adiponectin sensitizes insulin signaling by reducing p70 S6 kinase mediated serine phosphorylation of IRS-1","volume":"282","author":"Wang","year":"2007","journal-title":"J. Biol. Chem."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/nature01705","article-title":"Cloning of adiponectin receptors that mediate antidiabetic metabolic effects","volume":"423","author":"Yamauchi","year":"2003","journal-title":"Nature"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"4542","DOI":"10.1210\/jc.2005-0372","article-title":"Circulating adiponectin levels are associated with better glycemic control, more favorable lipid profile, and reduced inflammation in women with type 2 diabetes","volume":"90","author":"Mantzoros","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1210\/jcem.86.5.7463","article-title":"Hypoadiponectinemia in Obesity and Type 2 Diabetes: Close Association with Insulin Resistance and Hyperinsulinemia","volume":"86","author":"Weyer","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"5662","DOI":"10.1210\/jc.2002-020635","article-title":"Differential regulation of adiponectin secretion from cultured human omental and subcutaneous adipocytes: Effects of insulin and rosiglitazone","volume":"87","author":"Motoshima","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1172\/JCI29126","article-title":"Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome","volume":"116","author":"Kadowaki","year":"2006","journal-title":"J. Clin. Investig."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1161\/CIRCULATIONAHA.106.618918","article-title":"Adiponectin and Coronary Heart Disease: A Prospective Study and Meta-Analysis","volume":"114","author":"Sattar","year":"2006","journal-title":"Circulation"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1093\/eurheartj\/ehl153","article-title":"Adiponectin is an independent predictor of all-cause mortality, cardiac mortality, and myocardial infarction in patients presenting with chest pain","volume":"27","author":"Cavusoglu","year":"2006","journal-title":"Eur. Heart J."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1210\/jc.2007-1436","article-title":"Prognostic value of adiponectin for cardiovascular disease and mortality","volume":"93","author":"Dekker","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"4007","DOI":"10.1111\/bph.13619","article-title":"Unravelling the adiponectin paradox: Novel roles of adiponectin in the regulation of cardiovascular disease","volume":"174","author":"Woodward","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"ref_43","unstructured":"World Health Organization (WHO) (1995). WHO Expert Committee on Physical Status: The Use and Interpretation of Anthropometry. Physical Status: The Use of and Interpretation of Anthropometry, Report of a WHO Expert Committee, WHO."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Tomlinson, D.J., Erskine, R.M., Morse, C.I., and Onamb\u00e9l\u00e9, G.L. (2019). Body fat percentage, body mass index, fat mass index and the ageing bone: Their singular and combined roles linked to physical activity and diet. Nutrients, 11.","DOI":"10.3390\/nu11010195"},{"key":"ref_45","first-page":"601","article-title":"Writing Group for the European Working Group on Sarcopenia in Older People 2 (EWGSOP2), and the E. G. for E. Sarcopenia: Revised European consensus on definition and diagnosis","volume":"48","author":"Bahat","year":"2019","journal-title":"Age Ageing"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"American Diabetes Association (2015). Classification and Diagnosis of Diabetes. Diabetes Care, 38, S8\u2013S16.","DOI":"10.2337\/dc15-S005"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.2337\/diacare.22.9.1462","article-title":"Insulin sensitivity indices obtained from oral glucose tolerance testing: Comparison with the euglycemic insulin clamp","volume":"22","author":"Matsuda","year":"1999","journal-title":"Diabetes Care"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"K\u00f6lbel, H., Hauffa, B.P., Wudy, S.A., Bouikidis, A., Della Marina, A., and Schara, U. (2017). Hyperleptinemia in children with autosomal recessive spinal muscular atrophy type I-III. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0175611"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.nmd.2021.02.002","article-title":"Glucose and lipid metabolism disorders in children and adolescents with spinal muscular atrophy types 2 and 3","volume":"31","author":"Djordjevic","year":"2021","journal-title":"Neuromuscul. Disord."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Park, A.J., Battaglino, R.A., Nguyen, N.M.H., and Morse, L.R. (2018). Associations between lean mass and leptin in men with chronic spinal cord injury: Results from the FRASCI-muscle study. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0198969"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1600-0404.2009.01237.x","article-title":"Leptin and the metabolic syndrome in patients with myotonic dystrophy type 1","volume":"121","author":"Peric","year":"2010","journal-title":"Acta Neurol. Scand."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1038\/ijo.2008.233","article-title":"Physiological and pathophysiological roles of adiponectin and adiponectin receptors in the integrated regulation of metabolic and cardiovascular diseases","volume":"32","author":"Yamauchi","year":"2008","journal-title":"Int. J. Obes."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"108706","DOI":"10.1016\/j.jdiacomp.2024.108706","article-title":"Relationship between adiponectin and muscle mass in patients with metabolic syndrome and obesity","volume":"38","author":"Primo","year":"2024","journal-title":"J. Diabetes Complic."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Komici, K., Dello Iacono, A., De Luca, A., Perrotta, F., Bencivenga, L., Rengo, G., Rocca, A., and Guerra, G. (2021). Adiponectin and Sarcopenia: A Systematic Review with Meta-Analysis. Front. Endocrinol., 12.","DOI":"10.3389\/fendo.2021.576619"},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Harada, H., Kai, H., Shibata, R., Niiyama, H., Nishiyama, Y., Murohara, T., Yoshida, N., Katoh, A., and Ikeda, H. (2017). New diagnostic index for sarcopenia in patients with cardiovascular diseases. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0178123"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s00415-017-8405-3","article-title":"Correlation of insulin resistance and motor function in spinal and bulbar muscular atrophy","volume":"264","author":"Nakatsuji","year":"2017","journal-title":"J. Neurol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"101611","DOI":"10.1016\/j.arr.2022.101611","article-title":"Searching for the link between inflammaging and sarcopenia","volume":"77","author":"Wang","year":"2022","journal-title":"Ageing Res. Rev."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/nm1557","article-title":"Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions","volume":"13","author":"Yamauchi","year":"2007","journal-title":"Nat. Med."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"30817","DOI":"10.1074\/jbc.M402367200","article-title":"Insulin\/Foxo1 pathway regulates expression levels of adiponectin receptors and adiponectin sensitivity","volume":"279","author":"Tsuchida","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1093\/aje\/kwk001","article-title":"Association of adiponectin with coronary heart disease and mortality: The Rancho Bernardo study","volume":"165","author":"Laughlin","year":"2007","journal-title":"Am. J. Epidemiol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"5677","DOI":"10.1210\/jc.2005-0825","article-title":"Plasma adiponectin levels are associated with insulin resistance, but do not predict future risk of coronary heart disease in women","volume":"90","author":"Lawlor","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1093\/ije\/dyt087","article-title":"Association between adiponectin levels and coronary heart disease and mortality: A systematic review and meta-analysis","volume":"42","author":"Park","year":"2013","journal-title":"Int. J. Epidemiol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.diabet.2016.07.027","article-title":"Low adiponectin levels at baseline and decreasing adiponectin levels over 10 years of follow-up predict risk of the metabolic syndrome","volume":"43","author":"Lindberg","year":"2017","journal-title":"Diabetes Metab."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/HJR.0b013e32833b09d9","article-title":"High adiponectin and increased risk of cardiovascular disease and mortality in asymptomatic older men: Does NT-proBNP help to explain this association?","volume":"18","author":"Wannamethee","year":"2011","journal-title":"Eur. J. Cardiovasc. Prev. Rehabil."}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/15\/5\/529\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:39:57Z","timestamp":1760027997000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/15\/5\/529"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,21]]},"references-count":65,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,3]]}},"alternative-id":["diagnostics15050529"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics15050529","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,21]]}}}